As of 2025-07-11, the Fair Value of Hyundai Pharmaceutical Co Ltd (004310.KS) is -547.21 KRW. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3,515.00 KRW, the upside of Hyundai Pharmaceutical Co Ltd is -115.57%.
With the market price of 3,515.00 KRW and our fair value calculation, Hyundai Pharmaceutical Co Ltd (004310.KS) is not a good investment. Investing in 004310.KS stocks now will result in a potential loss of 115.57%.
Note: valuation result may not be accurate due to the low predictability of business.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 5Y Avg | |
| Net income | 2,187.00 | -3,173.18 | -164.58 | 6,121.76 | -574.89 | 879.22 |
| YoY growth | 80.30% | -245.09% | 94.81% | 3,819.55% | -109.39% | 728.04% |
| Market Cap (mil) | 112,480.00 |
| P/E | |
| Forward P/E | 466.11x |
| EPS | -21.89 |
| Avg earnings growth rate | 728.04% |
| TTM earnings |